Oral Vaccine Advantage Mazen’s corn-seed based oral vaccines offer a scalable alternative to injectable vaccines, presenting a compelling value proposition for animal producers seeking easier administration, improved safety for staff, and potential reductions in labor costs.

Ambient Stability The vaccine platform’s ambient temperature stability enables distribution to regions with limited cold-chain infrastructure, creating sales opportunities in emerging markets and remote farming operations.

Reduced Antibiotics By eliciting mucosal and systemic immunity through feed-delivered vaccines, Mazen positions potential to reduce antibiotic usage, aligning with industry trends and regulatory pressure to lower antimicrobial reliance.

Evidence Ready Proof-of-efficacy data for two vaccine candidates supports early-stage differentiation; target customers include producers facing unmet disease prevention needs who value demonstrated performance.

Growth Readiness With a Series A in place and a growing team, Mazen shows momentum; sales outreach can focus on strategic partnerships with mid-sized to large poultry and swine operations seeking innovative, cost-structure-friendly vaccines.